- 4.8Impact Factor
- 7.7CiteScore
- 16 daysTime to First Decision
Special Issues
Pharmaceuticals publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
New Structural, Biophysical and Computational Perspectives on the Use of Proteins in Drug Design and Discovery
Deadline: 31 October 2026
Pharmacotherapy of Thromboembolism
Deadline: 25 October 2026
New Advances in Antiarrhythmic Drugs
Deadline: 20 October 2026
Multi-Targeted Natural Products as Therapeutics, 2nd Edition
Deadline: 30 September 2026
Omics Approaches in Drug Discovery, Precision Therapy, and Disease Prevention
Deadline: 30 September 2026
Recent Advancements in the Development of Antiprotozoal Agents: 2nd Edition
Deadline: 25 September 2026
Plant-Based Extracts and the Therapeutic Potential of Bioactive Compounds, 2nd Edition
Deadline: 31 August 2026
A Commemorative Special Issue in Honor of Professor Carlos Alberto Manssour Fraga: Medicinal Chemistry’s Efforts to Discover Novel Bioactive Molecules for Complex Diseases
Deadline: 28 August 2026
Hybrid and Chimeric Heterocycles: A Promising Approach to Synthesizing Biologically Active Compounds
Deadline: 31 July 2026
Pharmacology and Toxicology of Opioids, 2nd Edition
Deadline: 31 July 2026
The Nuclear Factor Kappa-B (NF-κB) Pathway as a Target for Drug Discovery
Deadline: 31 July 2026
Recent Advances in Medicinal Plants and Plant-Derived Compounds: Neuroprotective, Anti-Inflammatory, Antioxidant, Anticancer, and Antimicrobial Applications
Deadline: 31 July 2026
of 81

